Ezetimibe/Rosuvastatin

DRUG6 trials

Sponsors

LG Chem, HK inno.N Corporation, Addpharma Inc., Daewoong Pharmaceutical Co. LTD., Celltrion Pharm, Inc.

Conditions

DyslipidemiasHealthy Male VolunteersHypercholesterolemiaHypertensionHypertension, Hyperlipidemia

Phase 1

Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802

CompletedNCT03532854

LG ChemHealthy Male Volunteers

Start: 2018-05-28End: 2019-01-30Updated: 2019-02-15

Phase 3

Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan

CompletedNCT03872232

Addpharma Inc.Hypercholesterolemia, Hypertension

Start: 2019-02-26End: 2020-08-12Updated: 2021-01-15

Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine

CompletedNCT04158076

Addpharma Inc.Hypercholesterolemia, Hypertension

Start: 2020-01-23End: 2021-01-14Updated: 2021-05-12

Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol

CompletedNCT07564726

Celltrion Pharm, Inc.Hypercholesterolemia, Hypertension

Start: 2022-08-05End: 2024-02-13Updated: 2026-05-08

Phase 4

Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets

CompletedNCT03847506

HK inno.N CorporationHypertension, Hyperlipidemia

Start: 2018-07-05End: 2020-12-02Updated: 2022-05-10

Unknown Phase

A Study to Evaluate the Efficacy and Safety of CREZET Tablet

Active, not recruitingNCT05889143

Daewoong Pharmaceutical Co. LTD.Dyslipidemias

Start: 2023-05-24End: 2026-03-01Target: 15000Updated: 2025-08-24